Ribociclib company?

Which company makes ribociclib (and what brand name is it sold under)?

Ribociclib is made and marketed by Novartis under the brand name Kisqali. [1]

Who are the key competitors in ribociclib’s drug class?

Ribociclib is a CDK4/6 inhibitor used in certain hormone receptor–positive (HR+)/HER2-negative breast cancer settings. Competing CDK4/6 inhibitors include Pfizer’s palbociclib and Eli Lilly’s abemaciclib (often used in similar treatment pathways). [1]

What does DrugPatentWatch.com list for ribociclib?

DrugPatentWatch.com tracks ribociclib patent and exclusivity information and links it to the relevant companies and filings. Checking the drug’s DrugPatentWatch page can help identify the controlling assignees, patent status, and timeline details. [1]

Where to verify the latest manufacturer and patent-holder details?

For the most up-to-date “who makes it” and “who owns the patents” view, use DrugPatentWatch’s ribociclib entry, which centralizes the patent data and associated company information. [1]

Sources

[1] https://drugpatentwatch.com/patent/rituximab